Product
Sodium Stibogluconate
2 clinical trials
2 indications
Indication
Cutaneous LeishmaniasisIndication
Visceral LeishmaniasisClinical trial
Documentation of Patient Outcomes for the Combination Treatment of Sodium Stibogluconate and Allopurinol in Complicated Cutaneous Leishmaniasis in EthiopiaStatus: Completed, Estimated PCD: 2022-12-15
Clinical trial
A Randomized, Open-label, Phase II, Single-centre Study to Evaluate the Efficacy, Safety and Pharmacokinetics of LXE408 in Patients With Primary Visceral Leishmaniasis in EthiopiaStatus: Recruiting, Estimated PCD: 2025-06-30